TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2013

Phase II study of gemcitabine, carboplatin, and bevacizumab in patients with advanced unresectable or metastatic urothelial cancer.

Arjun V Balar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.